Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer

Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer

Animal study shows how chemical compound in Indian Long Pepper works against glioblastoma

Animal study shows how chemical compound in Indian Long Pepper works against glioblastoma

New nanomedicine device is effective for treating glioblastoma multiforme

New nanomedicine device is effective for treating glioblastoma multiforme

POT1 gene linked to glioma development mediates its effects in a sex-specific manner

POT1 gene linked to glioma development mediates its effects in a sex-specific manner

Researchers decipher the molecular underpinning of exceptional responses in glioblastoma patients

Researchers decipher the molecular underpinning of exceptional responses in glioblastoma patients

An ion pump tested as a possible method to treat malignant brain tumors

An ion pump tested as a possible method to treat malignant brain tumors

Experts to discuss advanced cancer cell and gene therapies at Summit 2021

Experts to discuss advanced cancer cell and gene therapies at Summit 2021

Research may lead to a significant breakthrough in the battle against deadly brain tumors

Research may lead to a significant breakthrough in the battle against deadly brain tumors

Giving chemotherapy in the morning can extend survival of glioblastoma patients

Giving chemotherapy in the morning can extend survival of glioblastoma patients

Study reveals the structure of key enzyme that may advance cancer research

Study reveals the structure of key enzyme that may advance cancer research

Novel gene therapy reprograms glioma cells into functional neurons

Novel gene therapy reprograms glioma cells into functional neurons

Gene responsible for cholesterol dysregulation in brain cancer cells could be a target for future drugs

Gene responsible for cholesterol dysregulation in brain cancer cells could be a target for future drugs

Doctors found jet fuel in veteran’s lungs. He can’t get full benefits.

Doctors found jet fuel in veteran’s lungs. He can’t get full benefits.

Alliance for Cancer Gene Therapy provides new opportunity to develop cancer cell and gene therapies

Alliance for Cancer Gene Therapy provides new opportunity to develop cancer cell and gene therapies

UAB researchers find potential new pathway to treating radiation-resistant glioblastoma

UAB researchers find potential new pathway to treating radiation-resistant glioblastoma

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

Study opens the door to new possibilities targeting telomeres to help treat cancer

Study opens the door to new possibilities targeting telomeres to help treat cancer

Three projects from University of Colorado Cancer Center receive grants for brain tumor research

Three projects from University of Colorado Cancer Center receive grants for brain tumor research

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

Salk Institute uses $1 million gift to support world class cancer researcher

Salk Institute uses $1 million gift to support world class cancer researcher